
Akhil A Saji
@asajimd
Urologist @ProvSwedish via @USC_Urology, @NYMCUrology, @HUMCUrology. Editor for @GUOncologyNow. Opinions are my own. RTs ≠ Endorsements. Try CPTcalc.net
ID: 762824760623529984
http://asaji.me 09-08-2016 01:36:10
316 Tweet
325 Followers
617 Following


First single center RCT in the modern era to show a treatment effect on metastasis. Extended LND during radical prostatectomy superior to limited LND europeanurology.com/article/S0302-… Karim Touijer


There was a small yet significant change during the last Donald J. Trump administration led by Administrator Seema Verma that many outside healthcare may not know: the elimination of the Review of Systems (ROS) requirement. To understand why this mattered to physicians, here's some context:

📺 At the AUA Western Section meeting in Hawaii, GU Oncology Now section editor Dr. Akhil Saji and Amir Lebastchi, MD discuss the advancements and applications of focal therapy for #prostatecancer, exploring current standards and ideal patient selection: buff.ly/41BYri8





New third gen sp instruments are a dramatic improvement. Extended range ability going to be a game changer Sp nephrectomy via low anterior access. Akhil A Saji, MD

sp extraperitoneal RALP with extended range instruments. Extra grip and retraction on force bipolar and cardiere made posterior dissection and nerve sparing much easier. Suturing also felt much more natural Akhil A Saji, MD

LAA SP Partial Nephrectomy w Gen3 instruments🎥 Resection: Gen3✂️= tumor resection w/ greater ROM Renorrhaphy: L ✋🏽: Gen1 driver = limited strength & ROM R ✋🏽: NEW Gen3 driver = greater strength & ROM Gen3 = partials just like on Xi 🥂 Rogerio Huang Mickey Bindra Intuitive

Published in Urology Gold Journal the report of the developement of an #AI-based #software created for autonomous fusion of #TRUS and #MRI images of the #prostate. Kudos to the team, particularly to f.cianflone who lead and discussed this project to graduate as a specialist in #urology,



Another Retro SP LAA partial example with Gen3 Instruments. Enhanced range of motion and articulation improve speed, efficacy and accessibility of partial nephrectomy. Get in and get out 🚀 Rogerio Huang Mickey Bindra


Just in time for AUA - A high-quality succinct review on contemporary intravesical therapy on NMIBC by the great Saum Ghodoussipour & all ⭐️ colleagues in European Urology Beautiful figures too! A valuable resource for patients & urologists Bladder Cancer Advocacy Network YUO pubmed.ncbi.nlm.nih.gov/40253283/


Are there limits to SP LAA partial nephrectomy? What's the largest or most complex tumor you've managed with this approach? Sharing an example: a large, predominantly anterior upper pole tumor addressed via SP retro LAA. Rogerio Huang Mickey Bindra David Ambinder Mutahar Ahmed

Joshua Meeks provides an amazing overview of the significant data emerging in the BCG-unresponsive NMIBC space, focusing on the CIS cohorts. We also discuss the recent ODAC decision on UGN-102 for lower risk disease which was recently FDA approved. spotifycreators-web.app.link/e/szAiuFvyaUb


Molecular and Therapeutic Landscape of Non-Clear Cell Renal Cell Carcinoma: 🧬🧬🧬Diverse subtypes, unique genetics, unpredictable responses. Nature Reviews Urology OncoAlert KidneyCAN IKCC Kidney Cancer Kidney Cancer Reza Mehrazin, MD rdcu.be/ewjT8
